A New High Resolution PET Scanner with PEMView(TM) Software
SAN DIEGO, Nov. 27 /PRNewswire/ -- Naviscan PET Systems Inc., a
privately held company that manufactures and develops high-resolution PET
scanners launched its second generation of PEM devices, the PEM Flex(TM)
Solo II at the annual Radiological Society of North America (RSNA) in
Chicago, IL.
PEM Flex Solo II is the first commercially available FDA-cleared,
organ- specific, high- resolution PET scanner. Solo II is intended for use
as an adjunct imaging modality and utilizes Positron Emission Mammography
(PEM). PEM is a specialized form of PET technology that provides
radiologists, breast surgeons, oncologists and nuclear medicine a new tool
to image and characterize the scope of the disease at a metabolic rate.
Photonics improvements in the new Solo II yields higher count rate
sensitivity while maintaining resolution capabilities that image cancers as
small as 1.5 - 2.0mm, unprecedented in any other modality. The Solo II has
also added an articulating arm, a motorized C-arm, and compression
capability, enabling technologists to more easily position patients for
optimal views and improved chest wall access.
In addition to its superior resolution capabilities, studies have shown
the PEM Flex system has demonstrated sensitivity and specificity greater
than 90% for characterizing suspicious lesions. The system has a positive
predictive value of 92%.
Dr. Judy Kalinyak, MD, PhD, internist, endocrinologist, and nuclear
medicine specialist, recently joined Naviscan as Medical Director. "We are
very excited about the clinical trials with PEM in 2007. I believe it will
change how we screen and diagnose breast cancer, specifically in the in
situ stage, thereby reducing morbidity and mortality."
Also featured at the RSNA is PEMView, a companion image viewing and
interpretation software. PEMView incorporates user-configurable image
analysis tools as well as an embedded lexicon for effortless, standardized
report generation. PEMView is the first of its kind web-based system
allowing for flexible workflow options.
Dr. Kathy Schilling MD, Medical Director of Breast Imaging and
Intervention at the Center for Breast Care at the Boca Raton Community
Hospital in Florida is currently using the PEM Flex system to compare
breast PEM to breast MRI and whole body PET in the pre-op staging of
patients with recently diagnosed invasive or non-invasive breast cancer.
"PEM technology has been highly successful in identifying additional
disease in the same and opposite breast and provides excellent sensitivity,
improved specificity and ease of interpretation for the physician,"
explained Dr. Schilling.
For more information, please visit our website at http://www.naviscanpet.com
or contact:
Tom Watlington Sherri Antoniak
President Vice President, Corporate Development
Naviscan PET Systems, Inc. Naviscan PET Systems, Inc.
858-587-3641 ext. 104 858-587-3641 ext. 113
About Naviscan PET Systems, Inc.
Naviscan PET Systems, founded in 1995, develops and markets compact,
high-resolution PET scanners and molecular agents used for high-resolution
imaging. These products are designed to help physicians and researchers
diagnose and locate cancer, guide interventions, and advance new clinical
therapies. The Company is headquartered in San Diego, California.
SOURCE Naviscan PET Systems Inc.
 back to top
Related links:
http://www.naviscanpet.com
CONTACT:
Tom Watlington, President, ext. 104, or
Sherri Antoniak, Vice President, Corporate Development, ext. 113,
both of Naviscan PET Systems, Inc., +1-858-587-3641
|
